Risk of first-time major cardiovascular event among individuals with newly diagnosed type 2 diabetes: data from Danish registers

AIMS/HYPOTHESIS: We aimed to examine whether individuals with initial omission of glucose-lowering drug treatment (GLDT), including those achieving initial remission of type 2 diabetes, may experience a higher risk of major adverse cardiovascular events (MACE) compared with well-controlled individua...

Descripción completa

Detalles Bibliográficos
Autores principales: Falkentoft, Alexander C., Gerds, Thomas Alexander, Zareini, Bochra, Knop, Filip K., Køber, Lars, Torp-Pedersen, Christian, Schou, Morten, Bruun, Niels E., Ruwald, Anne-Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541344/
https://www.ncbi.nlm.nih.gov/pubmed/37528178
http://dx.doi.org/10.1007/s00125-023-05977-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541344/
https://www.ncbi.nlm.nih.gov/pubmed/37528178
http://dx.doi.org/10.1007/s00125-023-05977-6

Ejemplares similares